학술논문
Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.
Document Type
journal article
Author
Source
British Journal of Cancer; Sep1994, Vol. 70 Issue 3, p526-530, 5p
Subject
Language
ISSN
00070920